Drug Study F
Drug Study F
Classification >Cephalosporins
Adverse Effects > Thrombophlebitis. diarrhea, nausea. Possibly seizure & angioedema. Tab: Hypersensitivity, hematologic, nervous system, musculoskeletal, genitourinary, hepatic, resp, CV reactions. > Convulsive seizure, dizziness, vertigo, ataxia, confusion, irritability, depression, weakness, headache, hearing loss & insomnia. Nervousness, malaise. Nausea, anorexia, dry mouth & sharp, unpleasant metallic taste, vomiting, abdominal discomfort & diarrhea. Thrombophlebitis after IV infusion. >Phlebitis, inflammation at the inj site, GI reactions eg nausea & vomiting.
Nursing Responsibities >Ask for history of allergy. >Report onset of loose stools or diarrhea. >Give the medication after meal. >Check IV site. >Monitor manifestations of hypersensitivity. Discontinue drug and report their appearance promptly.
Dazomet (Metronidazole)
>Infection due to susceptible anaerobic microorganism. >Vaginal infection including bacterial vaginosis.
>Should be taken with food. >Discontinue Meds immediately if symptoms of CNS toxicity develop. Monitor especially for seizures, and peripheral neuropathy.
Monowel (Cefoxitin)
>Cephalosporins
>Peritonitis & other intra-abdominal & intrapelvic infections; soft tissue infections.
>Determine history of hypersensitivity reactions to cephalosporins. >monitor manifestations of hypersensitivity. >Inspect injection sites regularly. Report evidence of inflammation and patients complaint of pain.
>Haemostatics
> Surgical trauma, illness, infections, drug intake, excessive fatigue. >for cell repair
>GI disorders, nausea, vomiting, anorexia, headache, impaired renal insufficiency, hypotension when IV is too rapid. >Gastrointestinal side effects associated with oral iron therapy have included nausea, constipation, anorexia, heartburn, vomiting, and diarrhea. These effects are generally doserelated
>Tab 600mg
>Calcium/with Vitamins
> Supplement for Ca deficiency & conditions that require increased Ca intake; may reduce the risk of osteoporosis later in life.
>upset stomach,
Vomiting, stomach pain, belching, constipation, dry mouth, increased urination, loss of appetite, metallic taste
>Tab
>Should be taken with food. >Ask I the patient if the patient has kidney disease.
>Acute cough of any etiology. Pre- & post-op cough sedation for surgical procedures & bronchoscopy.
>May be taken with or without food. > Ask history of hypersensitivity to butamirate citrate.
>Primary vol replacement in hypovolaemia & shock due to acute blood or fluid loss, prophylaxis of hypotension during epidural or spinal anesth; >Reduce pain. >Use to decrease allergic symptomtology.
>As w/ all colloidal vol substitutes, allergic, (anaphylactic or anaphylactoid) reactions of varying severity can occur after infusion of Gelofusine. >Sedation, depression, irritability, paranoid psychosis, delusion, hallucination. Muscular weakness, incoordination. GIT disturbances. Headache, tinnitus. Difficulty in micturition. CV effects, hypotension or hypertension. >CNS: dizziness, headache >GI: nausea, dyspnea, edema, sweating, pain at injection site
>infusion 500mL
>tab 4mg >syrup2mg/5mL x 60mL >inj 10mg/mL x 1mL >vial 10mg/mL x 10mL
>May be taken with or without food >Monitor BP in hypertensive patients. >Advise the patient not to take alcohol, because antihistamines have addictive effects with alcohol.
>Monitor urine output in older adults and patients with history of cardiac decompensation, renal impairment, heart failure or liver dysfunction as well as those who are taking diuretics. >Monitor fluid retention and edema in patients with history of CHF. >Observe and report signs of bleeding. >Monitor BP for hypertension and blood sugar for hyperglycemia. >Monitor signs and symptoms of CHF including weight gain. >Monitor for signs and symptoms of GI irritation and ulceration.